InvestorsHub Logo
Followers 99
Posts 2761
Boards Moderated 2
Alias Born 02/10/2004

Re: None

Tuesday, 09/27/2005 4:37:51 PM

Tuesday, September 27, 2005 4:37:51 PM

Post# of 33753
BLLI has had 40% growth in revenue this year, before their recent expansion of their U.S. sales force and the expansion of their overseas distribution network.

These slides from their investor presentation in August in New York contain some more great information:
http://www.sec.gov/Archives/edgar/data/840573/000114420405024754/ex99-2.htm

These are what I considered some of the highlights:

1.) 42% increase in YTD sales without increasing sales force or distributors.

2.) Distribution is expanding to Japan, France, and the UAE now in September '05.

3.) They just began sales in the U.S. last year....and only had 5 U.S. sales people at the time of this presentation....but plan to triple that number for solid geographic coverage.

4.) I also found it interesting to learn that Chip Jones, who BLLI hired as V.P. of Marketing a few months ago, came from Implant Innovations International (3I)....the second largest U.S. Dental Implant company owned by Biomet (NASDAQ: BMET).

5.) They have 3 research studies that will be completed this fall (NYU - Laser Lok, UMDNJ - Laser Lok, and NYU - Bone Gen TR study).

After reviewing that presentation, I think the recent 40% sales growth is just the beginning of what could be a very strong growth trend for this company. They seam to be taking all the necessary steps of building a marketing team, sales force, and clinical data needed to support significant sales growth of their Laser Lok dental implant.....and the launch of their BoneGen TR product next spring

I've been adding BLLI here @ $1.60 really just for the potential organic growth of LaserLok......and BoneGen TR when it is released.

But I also think there's a bit of a wild card to this company with some of their less publicized research. This company is actually doing some very interesting nanotech and biotech research and just not selling it much to investors. Some of this stuff could really generate some market mayhem if they ever decide to publicize it.

This guy on RB finds some great info. on this R&D the company doesn't really publicize. This post summarizes some research they did with Princeton on their Laser microtexturing:
http://ragingbull.lycos.com/mboard/boards.cgi?board=BLLI&read=171

Then pay close attention to this third point "Mechanical/Neural Limb Prosthetic Interface". This stuff is really amazing!!! Bio Lok just might be developing the technology to make The Stepford Wives a reality! Just kidding! But this research could obviously have huge implications for prosthetic limbs if it works....and the Phase II NIH grant is slated to be complete in October:
http://ragingbull.lycos.com/mboard/boards.cgi?board=BLLI&read=154

But as a word od caution, I wouldn't expect to hear anything about this, since the company has not talked about it much in the past. I'm really just expecting nice and steady sales increases in the coming year and beyond.



"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.